Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

News and press releases

Get the latest updates from News and press releases directly as they happen.

Follow now 115 followers

Latest posts

Last updated 1 day ago

Call for expressions of interest for civil society representatives to participate in work of EMA , PRAC, 22/09/2021

4 days ago

The European Commission has launched calls for expressions of interest to represent...

New add-on treatment for rare autoimmune inflammatory disorder, CHMP, 17/09/2021

9 days ago

EMA has recommended granting an extension of indication to Nucala (mepolizumab) as...

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 September 2021, CHMP, 17/09/2021

9 days ago

Nine new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended nine...

Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 7-9 September 2021, CVMP, 10/09/2021

16 days ago

CVMP opinions on veterinary medicinal productsThe Committee adopted by majority a positive...

Increase in manufacturing capacity for COVID-19 vaccine from BioNTech/Pfizer, CHMP, 09/09/2021

17 days ago

EMA’s human medicines committee (CHMP) has approved additional manufacturing sites for the...

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021, PRAC, 03/09/2021

23 days ago

COVID-19 vaccines: EMA reviewing cases of multisystem inflammatory syndromeEMA’s safety committee (PRAC)...

ECDC and EMA highlight considerations for additional and booster doses of COVID-19 vaccines, , 02/09/2021

24 days ago

Based on current evidence, there is no urgent need for the administration...

Increase in vaccine manufacturing capacity for COVID-19 vaccines from BioNTech / Pfizer and Moderna, CHMP, 24/08/2021

about 1 month ago

EMA’s human medicines committee (CHMP) has adopted recommendations that will increase manufacturing...

EMA starts evaluating use of RoActemra in hospitalised adults with severe COVID-19, CHMP, 16/08/2021

about 1 month ago

EMA has started evaluating the anti-inflammatory medicine RoActemra (tocilizumab) to extend its...

Artificial intelligence in medicine regulation, , 16/08/2021

about 1 month ago

The International Coalition of Medicines Regulatory Authorities (ICMRA) sets out recommendations to...

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5 August 2021, PRAC, 06/08/2021

about 2 months ago

COVID-19 Vaccine Janssen: update on safety issuesThe PRAC recommended updating the product...